190 related articles for article (PubMed ID: 15984946)
1. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
Kumar J; Shaver MJ; Abul-Ezz S
Transpl Infect Dis; 2005 Mar; 7(1):30-3. PubMed ID: 15984946
[TBL] [Abstract][Full Text] [Related]
2. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
3. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.
Bergen GA; Sakalosky PE; Sinnott JT
J Heart Lung Transplant; 1996 Aug; 15(8):843-5. PubMed ID: 8878766
[TBL] [Abstract][Full Text] [Related]
4. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
Renoult E; Bachelet C; Krier-Coudert MJ; Diarrassouba A; André JL; Kessler M
Transplant Proc; 2006 Sep; 38(7):2321-3. PubMed ID: 16980079
[TBL] [Abstract][Full Text] [Related]
5. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
6. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.
Shen Q; Xu H; Cao Q; Zhou LJ; Xu J; Fang XY; Ge J
Pediatr Transplant; 2011 Jun; 15(4):E76-9. PubMed ID: 20136725
[TBL] [Abstract][Full Text] [Related]
7. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
Hartmann JT; Meisinger I; Kröber SM; Weisel K; Klingel K; Kanz L
Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
9. [Congenital aplastic anemia caused by parvovirus B19 infection].
Vepreková L; Jelínek J; Zeman J
Cas Lek Cesk; 2001 Mar; 140(6):178-80. PubMed ID: 11347208
[TBL] [Abstract][Full Text] [Related]
10. Unexplained chronic anemia and leukopenia in lung transplant recipients secondary to parvovirus B19 infection.
Shekar K; Hopkins PM; Kermeen FD; Dunning JJ; McNeil KD
J Heart Lung Transplant; 2008 Jul; 27(7):808-11. PubMed ID: 18582815
[TBL] [Abstract][Full Text] [Related]
11. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.
Becker MR; Schneider B; Reber U; Pöge U; Klein B; Klehr HU; Zhou H; Fischer HP; Eis-Hübinger AM
Transplant Proc; 2005 Dec; 37(10):4306-8. PubMed ID: 16387104
[TBL] [Abstract][Full Text] [Related]
12. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.
Plentz A; Hahn J; Holler E; Jilg W; Modrow S
J Clin Virol; 2004 Sep; 31(1):16-9. PubMed ID: 15288608
[TBL] [Abstract][Full Text] [Related]
13. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?
Gosset C; Viglietti D; Hue K; Antoine C; Glotz D; Pillebout E
Transpl Infect Dis; 2012 Oct; 14(5):E64-70. PubMed ID: 22931551
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.
Arzouk N; Snanoudj R; Beauchamp-Nicoud A; Mourad G; Charpentier B; Tchernia G; Durrbach A
Transpl Int; 2006 Feb; 19(2):166-9. PubMed ID: 16441366
[TBL] [Abstract][Full Text] [Related]
15. Increase in B19 viral load prior to relapse of anaemia in an AIDS patient with persistent B19 infection.
Hung CC; Lee KL; Chen MY
J Infect; 2001 Aug; 43(2):150-2. PubMed ID: 11676524
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 infection in an isolated pancreas transplant recipient.
Onitilo AA; Shaw GR
Transplant Proc; 2005 Dec; 37(10):4433-5. PubMed ID: 16387138
[TBL] [Abstract][Full Text] [Related]
17. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.
Tang JW; Lau JS; Wong SY; Cheung JL; Chan CH; Wong KF; Wong A; Chan PK
J Med Virol; 2007 Sep; 79(9):1401-5. PubMed ID: 17607784
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
19. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.
Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E
Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205
[TBL] [Abstract][Full Text] [Related]
20. [Familial transient red cell aplasia from parvovirus B-19 infection].
Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
